Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barnhill

Showing results (631-640 of 694) with videos related to

Pageof 70
Sort By:
British Journal of Cancer|July 13, 2023
Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastasesPascale Mariani, Nouritza Torossian, Steven van Laere, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 4, 2023
A Multicenter Study Validates the WHO 2022 Classification for Conjunctival Melanocytic Intraepithelial Lesions With Clinical and Prognostic RelevanceHardeep Singh Mudhar, Yamini Krishna, Simon Cross, et al.
Transplantation Proceedings|September 24, 2025
Simultaneous Heart-Liver Transplant Using Dual-Organ Normothermic Machine Perfusion Following Donation After Circulatory Death: A Case ReportStephanie Y Ohara, Usman Aslam, Lisa M Lemond, et al.
American Journal of Clinical Pathology|August 23, 2003
Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions?Victor G Prieto, Zsolt B Argenyi, Raymond L Barnhill, et al.
BMJ Open|January 14, 2025
Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised studyZhuohan Wu, Brooke Nickel, Farzaneh Boroumand, et al.
Pigment Cell & Melanoma Research|September 30, 2010
Genetic and morphologic features for melanoma classificationSigrid M C Broekaert, Ritu Roy, Ichiro Okamoto, et al.
Cancer|October 22, 2016
An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic neviLoren E Clarke, Darl D Flake, Klaus Busam, et al.
Nature Communications|May 16, 2018
Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumorsManuel Rodrigues, Lenha Mobuchon, Alexandre Houy, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patientsMathilde Saint-Ghislain, Anne-Céline Derrien, Lionnel Geoffrois, et al.
Cancer Journal (Sudbury, Mass.)|July 6, 2000
Adjuvant high-dose interferon alfa-2b in patients with high-risk melanomaE Jonasch, U N Kumar, G P Linette, et al.
Pageof 70

Showing results (631-640 of 694) with videos related to

Sort By:
Pageof 70
British Journal of Cancer|July 13, 2023
Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastasesPascale Mariani, Nouritza Torossian, Steven van Laere, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 4, 2023
A Multicenter Study Validates the WHO 2022 Classification for Conjunctival Melanocytic Intraepithelial Lesions With Clinical and Prognostic RelevanceHardeep Singh Mudhar, Yamini Krishna, Simon Cross, et al.
Transplantation Proceedings|September 24, 2025
Simultaneous Heart-Liver Transplant Using Dual-Organ Normothermic Machine Perfusion Following Donation After Circulatory Death: A Case ReportStephanie Y Ohara, Usman Aslam, Lisa M Lemond, et al.
American Journal of Clinical Pathology|August 23, 2003
Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions?Victor G Prieto, Zsolt B Argenyi, Raymond L Barnhill, et al.
BMJ Open|January 14, 2025
Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised studyZhuohan Wu, Brooke Nickel, Farzaneh Boroumand, et al.
Pigment Cell & Melanoma Research|September 30, 2010
Genetic and morphologic features for melanoma classificationSigrid M C Broekaert, Ritu Roy, Ichiro Okamoto, et al.
Cancer|October 22, 2016
An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic neviLoren E Clarke, Darl D Flake, Klaus Busam, et al.
Nature Communications|May 16, 2018
Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumorsManuel Rodrigues, Lenha Mobuchon, Alexandre Houy, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patientsMathilde Saint-Ghislain, Anne-Céline Derrien, Lionnel Geoffrois, et al.
Cancer Journal (Sudbury, Mass.)|July 6, 2000
Adjuvant high-dose interferon alfa-2b in patients with high-risk melanomaE Jonasch, U N Kumar, G P Linette, et al.
Pageof 70